dimethoxyphenylethylamine has been researched along with Seizures in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunt, TM; de Ruijter, W; Jager, N; Krens, SD; LeCouffe, NE; Louwerens, JKG; Spoelder, AS | 1 |
| Gerona, RR; Hoehn, S; Thornton, SL | 1 |
| Calvo, J; Elbakoush, F; Exantus-Bernard, G; Fong, J; Laskowski, LK; Nelson, LS; Poklis, A; Poklis, JL | 1 |
| Halberstadt, AL | 1 |
| Bosak, A; Levine, M; LoVecchio, F | 1 |
1 review(s) available for dimethoxyphenylethylamine and Seizures
| Article | Year |
|---|---|
Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
Topics: Animals; Dimethoxyphenylethylamine; Ethylamines; Fever; Hallucinogens; Humans; Iodobenzenes; Mice; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Rhabdomyolysis; Seizures; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship; Vasoconstriction | 2017 |
4 other study(ies) available for dimethoxyphenylethylamine and Seizures
| Article | Year |
|---|---|
Unexpected Serotonin Syndrome, Epileptic Seizures, and Cerebral Edema Following 2,5-dimethoxy-4-bromophenethylamine Ingestion.
Topics: Adolescent; Brain Edema; Chromatography, Liquid; Designer Drugs; Dimethoxyphenylethylamine; Humans; Male; Seizures; Serotonin Syndrome; Substance-Related Disorders; Tandem Mass Spectrometry | 2019 |
Seizures, Systemic Inflammatory Response, and Rhabdomyolysis Associated With Laboratory-Confirmed 2C-I and 25-I Exposure.
Topics: Adolescent; Anticonvulsants; Chromatography, Liquid; Designer Drugs; Diagnosis, Differential; Dimethoxyphenylethylamine; Humans; Male; Rhabdomyolysis; Seizures; Systemic Inflammatory Response Syndrome | 2018 |
Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
Topics: Adolescent; Anisoles; Benzodiazepines; Central Nervous System Stimulants; Creatine Kinase; Designer Drugs; Dimethoxyphenylethylamine; Female; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Mental Disorders; Muscle Rigidity; Phenethylamines; Receptor, Serotonin, 5-HT2A; Seizures; Serotonin 5-HT2 Receptor Agonists; Substance-Related Disorders | 2015 |
Recurrent seizures and serotonin syndrome following "2C-I" ingestion.
Topics: Adult; Designer Drugs; Dimethoxyphenylethylamine; Emergency Service, Hospital; Humans; Insufflation; Male; Phenethylamines; Respiratory Insufficiency; Seizures; Serotonin Syndrome; Substance-Related Disorders; Treatment Outcome; Young Adult | 2013 |